Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
OCV C01
i
Other names:
OCV C01, OCV-C01, peptide cocktail vaccine, OCVC01
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
OncoTherapy, Otsuka
Drug class:
Cytotoxic T lymphocyte stimulant
Related drugs:
‹
tretinoin (6)
INO-5401 (1)
DOC1021 (1)
CAN-3110 (1)
GL-ONC1 (1)
cytotoxic lymphocyte-based cancer vaccine (0)
CRX100 (0)
EO2401 (0)
EO2463 (0)
ET140203 (0)
GRANITE (0)
GSK2130579A (0)
GSK2302025A (0)
GX301 (0)
HA-1 T TCR T Cell Immunotherapy (0)
HSV G207 (0)
IMA-901 (0)
IMA910 (0)
MT-201 (0)
NC410 (0)
PGV-001 (0)
PV-001-DC (0)
RTX-321 (0)
SQZ-PBMC-HPV (0)
TBX-3400 (0)
tabelecleucel (0)
SB-313 (0)
AGI-134 (0)
S-588410 (0)
TBI-1401 (0)
mouse TYRP2 DNA (0)
tretinoin (6)
INO-5401 (1)
DOC1021 (1)
CAN-3110 (1)
GL-ONC1 (1)
cytotoxic lymphocyte-based cancer vaccine (0)
CRX100 (0)
EO2401 (0)
EO2463 (0)
ET140203 (0)
GRANITE (0)
GSK2130579A (0)
GSK2302025A (0)
GX301 (0)
HA-1 T TCR T Cell Immunotherapy (0)
HSV G207 (0)
IMA-901 (0)
IMA910 (0)
MT-201 (0)
NC410 (0)
PGV-001 (0)
PV-001-DC (0)
RTX-321 (0)
SQZ-PBMC-HPV (0)
TBX-3400 (0)
tabelecleucel (0)
SB-313 (0)
AGI-134 (0)
S-588410 (0)
TBI-1401 (0)
mouse TYRP2 DNA (0)
›
Associations
News
Trials
Filter by
Latest
over4years
Clinical Trial of a Cancer Vaccine Targeting VEGF and KIF20A in Advanced Biliary Tract Cancer. (PubMed, Anticancer Res)
The cancer vaccine had positive effects on survival, indicating that this approach warrants further clinical studies.
over 4 years ago
Clinical • Clinical Trial,Phase II • Journal
|
KDR (Kinase insert domain receptor) • VEGFA (Vascular endothelial growth factor A) • FLT1 (Fms-related tyrosine kinase 1)
|
OCV C01
Share via
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.